BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22093874)

  • 1. Evaluation of the NOD/SCID xenograft model for glucocorticoid-regulated gene expression in childhood B-cell precursor acute lymphoblastic leukemia.
    Bhadri VA; Cowley MJ; Kaplan W; Trahair TN; Lock RB
    BMC Genomics; 2011 Nov; 12():565. PubMed ID: 22093874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone resistance in B-cell precursor childhood acute lymphoblastic leukemia occurs downstream of ligand-induced nuclear translocation of the glucocorticoid receptor.
    Bachmann PS; Gorman R; Mackenzie KL; Lutze-Mann L; Lock RB
    Blood; 2005 Mar; 105(6):2519-26. PubMed ID: 15572593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
    Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
    Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical analysis of the γ-secretase inhibitor PF-03084014 in combination with glucocorticoids in T-cell acute lymphoblastic leukemia.
    Samon JB; Castillo-Martin M; Hadler M; Ambesi-Impiobato A; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Jakubczak J; Randolph S; Cordon-Cardo C; Ferrando AA
    Mol Cancer Ther; 2012 Jul; 11(7):1565-75. PubMed ID: 22504949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoids Inhibit Oncogenic RUNX1-ETO in Acute Myeloid Leukemia with Chromosome Translocation t(8;21).
    Lu L; Wen Y; Yao Y; Chen F; Wang G; Wu F; Wu J; Narayanan P; Redell M; Mo Q; Song Y
    Theranostics; 2018; 8(8):2189-2201. PubMed ID: 29721072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells.
    Jing D; Bhadri VA; Beck D; Thoms JA; Yakob NA; Wong JW; Knezevic K; Pimanda JE; Lock RB
    Blood; 2015 Jan; 125(2):273-83. PubMed ID: 25336632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of reproducible xenotransplantation model of T cell acute lymphoblastic leukemia in NOD/SCID mice.
    Wang D; Wang N; Zhang Y; Ma S; Geng Z; Zhou P; Zhou J; Huang L
    J Huazhong Univ Sci Technolog Med Sci; 2012 Aug; 32(4):511-516. PubMed ID: 22886962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of the deubiquitinase USP9X attenuates B-cell acute lymphoblastic leukemia cell survival and overcomes glucocorticoid resistance.
    Zhou M; Wang T; Lai H; Zhao X; Yu Q; Zhou J; Yang Y
    Biochem Biophys Res Commun; 2015 Apr; 459(2):333-339. PubMed ID: 25735983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse.
    Lock RB; Liem N; Farnsworth ML; Milross CG; Xue C; Tajbakhsh M; Haber M; Norris MD; Marshall GM; Rice AM
    Blood; 2002 Jun; 99(11):4100-8. PubMed ID: 12010813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte-Specific Chromatin Accessibility Pre-determines Glucocorticoid Resistance in Acute Lymphoblastic Leukemia.
    Jing D; Huang Y; Liu X; Sia KCS; Zhang JC; Tai X; Wang M; Toscan CE; McCalmont H; Evans K; Mayoh C; Poulos RC; Span M; Mi J; Zhang C; Wong JWH; Beck D; Pimanda JE; Lock RB
    Cancer Cell; 2018 Dec; 34(6):906-921.e8. PubMed ID: 30537513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoids and selumetinib are highly synergistic in RAS pathway-mutated childhood acute lymphoblastic leukemia through upregulation of BIM.
    Matheson EC; Thomas H; Case M; Blair H; Jackson RK; Masic D; Veal G; Halsey C; Newell DR; Vormoor J; Irving JAE
    Haematologica; 2019 Sep; 104(9):1804-1811. PubMed ID: 30655370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias.
    Morisot S; Wayne AS; Bohana-Kashtan O; Kaplan IM; Gocke CD; Hildreth R; Stetler-Stevenson M; Walker RL; Davis S; Meltzer PS; Wheelan SJ; Brown P; Jones RJ; Shultz LD; Civin CI
    Leukemia; 2010 Nov; 24(11):1859-66. PubMed ID: 20739953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent mechanisms of glucocorticoid resistance in experimental models of pediatric acute lymphoblastic leukemia.
    Bachmann PS; Gorman R; Papa RA; Bardell JE; Ford J; Kees UR; Marshall GM; Lock RB
    Cancer Res; 2007 May; 67(9):4482-90. PubMed ID: 17483364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuated measles virus controls pediatric acute B-lineage lymphoblastic leukemia in NOD/SCID mice.
    Lühl NC; Zirngibl F; Dorneburg C; Wei J; Dahlhaus M; Barth TF; Meyer LH; Queudeville M; Eckhoff S; Debatin KM; Beltinger C
    Haematologica; 2014 Jun; 99(6):1050-61. PubMed ID: 24700491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ENO2 Promotes Cell Proliferation, Glycolysis, and Glucocorticoid-Resistance in Acute Lymphoblastic Leukemia.
    Liu CC; Wang H; Wang WD; Wang L; Liu WJ; Wang JH; Geng QR; Lu Y
    Cell Physiol Biochem; 2018; 46(4):1525-1535. PubMed ID: 29689546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of glucocorticoid on the expression of Puma in acute lymphoblastic leukemia].
    Xu B; Wang BJ; Li AM; Lock R
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):151-4. PubMed ID: 16613713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID mice.
    Nijmeijer BA; Mollevanger P; van Zelderen-Bhola SL; Kluin-Nelemans HC; Willemze R; Falkenburg JH
    Exp Hematol; 2001 Mar; 29(3):322-9. PubMed ID: 11274760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Establishment of human acute B-lymphoblastic leukemia NOD/SCID/IL2 receptor γ chain(null) neonatal mouse xenotransplant model].
    Kong Y; Liu YR; Liu KY; Huang XJ; Ishikawa F; Harada M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):762-8. PubMed ID: 22739198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engraftment of low numbers of pediatric acute lymphoid and myeloid leukemias into NOD/SCID/IL2Rcγnull mice reflects individual leukemogenecity and highly correlates with clinical outcome.
    Woiterski J; Ebinger M; Witte KE; Goecke B; Heininger V; Philippek M; Bonin M; Schrauder A; Röttgers S; Herr W; Lang P; Handgretinger R; Hartwig UF; André MC
    Int J Cancer; 2013 Oct; 133(7):1547-56. PubMed ID: 23526331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAC2, AEP, and ICAM1 expression are associated with CNS disease in a mouse model of pre-B childhood acute lymphoblastic leukemia.
    Holland M; Castro FV; Alexander S; Smith D; Liu J; Walker M; Bitton D; Mulryan K; Ashton G; Blaylock M; Bagley S; Connolly Y; Bridgeman J; Miller C; Krishnan S; Dempsey C; Masurekar A; Stern P; Whetton A; Saha V
    Blood; 2011 Jul; 118(3):638-49. PubMed ID: 21606482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.